Fresenius Medical Care AG & Co. KGaA (FME) Given a €67.00 Price Target at Jefferies Financial Group

Share on StockTwits

Jefferies Financial Group set a €67.00 ($77.91) target price on Fresenius Medical Care AG & Co. KGaA (ETR:FME) in a research note released on Friday. The brokerage currently has a neutral rating on the stock.

Other equities analysts also recently issued reports about the company. Goldman Sachs Group set a €98.00 ($113.95) price target on Fresenius Medical Care AG & Co. KGaA and gave the company a buy rating in a report on Monday, October 1st. UBS Group set a €86.00 ($100.00) price target on Fresenius Medical Care AG & Co. KGaA and gave the company a neutral rating in a report on Wednesday, October 17th. Barclays set a €87.20 ($101.40) price target on Fresenius Medical Care AG & Co. KGaA and gave the company a neutral rating in a report on Wednesday, October 17th. Nord/LB set a €85.00 ($98.84) price target on Fresenius Medical Care AG & Co. KGaA and gave the company a buy rating in a report on Wednesday, October 17th. Finally, Credit Suisse Group set a €75.00 ($87.21) price target on Fresenius Medical Care AG & Co. KGaA and gave the company a neutral rating in a report on Wednesday, October 17th. Nine analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company’s stock. The company presently has a consensus rating of Buy and a consensus price target of €84.73 ($98.52).

FME traded down €0.34 ($0.40) on Friday, reaching €59.24 ($68.88). The company’s stock had a trading volume of 728,130 shares, compared to its average volume of 704,197. Fresenius Medical Care AG & Co. KGaA has a fifty-two week low of €75.53 ($87.83) and a fifty-two week high of €93.82 ($109.09).

Fresenius Medical Care AG & Co. KGaA Company Profile

Fresenius Medical Care AG & Co KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.

Featured Story: How can you know how many shares are floating?

Analyst Recommendations for Fresenius Medical Care AG & Co. KGaA (ETR:FME)

Receive News & Ratings for Fresenius Medical Care AG & Co. KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. KGaA and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

IslaCoin Price Hits $0.17 on Exchanges
IslaCoin Price Hits $0.17 on Exchanges
WP Carey Inc  Given Average Recommendation of “Hold” by Brokerages
WP Carey Inc Given Average Recommendation of “Hold” by Brokerages
Medtronic PLC  Given Consensus Recommendation of “Buy” by Analysts
Medtronic PLC Given Consensus Recommendation of “Buy” by Analysts
Zen Protocol Reaches 24 Hour Trading Volume of $240,660.00
Zen Protocol Reaches 24 Hour Trading Volume of $240,660.00
Zynerba Pharmaceuticals  Upgraded by Zacks Investment Research to Buy
Zynerba Pharmaceuticals Upgraded by Zacks Investment Research to Buy
Po.et Price Up 5.6% Over Last 7 Days
Po.et Price Up 5.6% Over Last 7 Days


Leave a Reply

© 2006-2019 Ticker Report